Convalescent Plasma News and Research

RSS
SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

SARS-CoV-2 immunity persists for up to 11 months after natural infection

SARS-CoV-2 immunity persists for up to 11 months after natural infection

Cell-to-cell contact helps in spreading SARS-CoV-2, finds study

Cell-to-cell contact helps in spreading SARS-CoV-2, finds study

What is the role of monoclonal antibody therapy in treating COVID-19?

What is the role of monoclonal antibody therapy in treating COVID-19?

Reduced use of convalescent plasma associated with higher COVID-19 mortality rate

Reduced use of convalescent plasma associated with higher COVID-19 mortality rate

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

SARS-CoV-2 evades neutralizing antibodies and rapidly spreads by cell fusion, finds study

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Hydroxychloroquine + Azithromycin therapy at a higher dose improved survival by nearly 200% in ventilated COVID patients

Long COVID patients at higher risk of small airway disease

Long COVID patients at higher risk of small airway disease

Study links barotrauma to COVID-19 in younger patients

Study links barotrauma to COVID-19 in younger patients

Nanobody inhalation found to be effective against COVID-19 in hamsters

Nanobody inhalation found to be effective against COVID-19 in hamsters

Facets of SARS-CoV-2 infection and animal models

Facets of SARS-CoV-2 infection and animal models

Researchers investigate antibodies that best neutralize SARS-CoV-2 in COVID-19 patients

Researchers investigate antibodies that best neutralize SARS-CoV-2 in COVID-19 patients

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Immunosuppression in COVID-19 promotes emergence of multiple immune escape mutants

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

Large-scale study focuses on COVID-19 antibodies in asymptomatic and symptomatic patients

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

About 84% of antibodies in plasma target non-RBD epitopes on SARS-CoV-2 spike protein, finds study

UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas

UT Southwestern reports first cases of Brazilian variant of COVID-19 infection in North Texas

Real-world study in India finds COVISHIELD vaccine safe and effective

Real-world study in India finds COVISHIELD vaccine safe and effective

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Immune escape by SARS-CoV-2 mutations acquired in mink

Immune escape by SARS-CoV-2 mutations acquired in mink

Chronic SARS-CoV-2 infections favor viral adaptation, says study

Chronic SARS-CoV-2 infections favor viral adaptation, says study